Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction. (2015)

First Author: Rawstron AC
Attributed to:  Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2014-07-590166

PubMed Identifier: 25645353

Publication URI: http://europepmc.org/abstract/MED/25645353

Type: Journal Article/Review

Volume: 125

Parent Publication: Blood

Issue: 12

ISSN: 0006-4971